HMC
Honda Motor Co., Ltd.
HMC has a slight edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
HMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
HMC's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HMC PE Valuation
HMC has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect HMC to return to profit, with revenue growing.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.81 | -131% |
| Q1 2026 | -$2.11 | -164% |
| Q4 2025 | $2.25 | -45% |
| Q3 2025 | $2.75 | -28% |
| Q2 2025 | $2.63 | -40% |
| Q1 2025 | $3.29 | -22% |
| Q4 2024 | $4.08 | +14% |
| Q3 2024 | $3.83 | +9.4% |
HMC has swung to a loss: it lost $0.81 per share over the past year, after a profit the year before.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over HMC on earnings, with more consistent year-over-year improvement.
HMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $38B | +14% |
| Q1 2026 | $36.5B | +8.6% |
| Q4 2025 | $33.5B | -3.4% |
| Q3 2025 | $33.2B | -1.9% |
| Q2 2025 | $33.5B | -1.2% |
| Q1 2025 | $33.6B | -1.3% |
| Q4 2024 | $34.7B | +2.6% |
| Q3 2024 | $33.8B | +8.2% |
HMC's revenue is growing: $38B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.8% | +4.2 points |
| Q1 2026 | -17% | -19 points |
| Q4 2025 | 2.9% | -4.3 points |
| Q3 2025 | 3.7% | -15 points |
| Q2 2025 | 4.6% | -4.4 points |
| Q1 2025 | 1.4% | -4.3 points |
| Q4 2024 | 7.2% | +0.1 points |
| Q3 2024 | 19% | +13 points |
HMC has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HMC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2B | -$1.4B |
| Q1 2026 | $870.1M | +$1.8B |
| Q4 2025 | $612.2M | +$1.3B |
| Q3 2025 | $726.9M | +$772.3M |
| Q2 2025 | -$719.2M | $0 |
| Q1 2025 | -$942.2M | $0 |
| Q4 2024 | -$683.5M | $0 |
| Q3 2024 | -$45.5M | $0 |
HMC has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +62.8M shares |
| 1 year | 0% | -42.7K shares |
| 3 years | -15% | -257M shares |
| 5 years | -19% | -326M shares |
| Available history | -20% | -359M shares |
HMC has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $576,658 |
| Q4 2025 | — |
| Q3 2025 | $1.9B |
| Q2 2025 | $2.3B |
| Q1 2025 | $2.7B |
| Q4 2024 | $423.3M |
| Q3 2024 | $1.3B |
HMC spent $1.9B buying back its own shares over the past year, down 71% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.8x | Moderate |
| Q3 2024 | 2.5x | Moderate |
HMC has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.9 | Neutral |
HMC's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HMC PE vs Consumer Cyclical Sector
| Metric | HMC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HMC has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.6 | 0.2% below |
| 20 week MA | $31.9 | 5.3% above |
| 50 week MA | $29.4 | 14% above |
| 100 week MA | $29.7 | 13% above |
| 200 week MA | $30.3 | 11% above |
HMC has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $28.6 | -0.1% |
| 2021 | $28.6 | $28.1 | -1.7% |
| 2022 | $28.1 | $23.1 | -18% |
| 2023 | $23.1 | $30.9 | +34% |
| 2024 | $30.9 | $28.8 | -7% |
| 2025 | $28.8 | $29.8 | +3.6% |
| 2026 YTD | $29.8 | $33.5 | +13% |
HMC has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.